More attention should be paid to the treatment of male infertility with drugs-testosterone: to use it or not?

被引:10
|
作者
Li, Hong-Jun [1 ]
机构
[1] Chinese Acad Med Sci, Peking Union Med Coll, PUMCH, Dept Urol, Beijing 100730, Peoples R China
关键词
TAMOXIFEN CITRATE; IN-VITRO; UNDECANOATE; MEN; SPERMATOGENESIS; AZOOSPERMIA; GUIDELINES; CULTURE; CELLS;
D O I
10.4103/1008-682X.122343
中图分类号
R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
摘要
Testosterone replacement is strictly contraindicated for the treatment of male infertility was the advanced view from the '2013 European Association of Urology (EAU) guidelines on male infertility', and this view brings extensive concern and questions. Although sufficient numbers of well-performed and controlled clinical trials that provide evidence supporting drug treatment of male infertility are not available at present, the opportunity to prove that these drugs are effective should not be prevented, and rigorous examination of drug therapy should be encouraged and strengthened. Therefore, I believe the above conclusion in the EAU guidelines is poorly conceived.
引用
收藏
页码:270 / 273
页数:4
相关论文
共 50 条